Summary- Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience long-term PFS compared to Nexavar® (sorafenib)…
FDA Approval
-
-
AgrochemicalsGlobal MarketPharma Science & Research
Cabenuva HIV Drug From GlaxoSmithKline Gets FDA Approval
by adminby adminSUMMARY – Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was…
-
Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed…
-
Synopsis : Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of…
-
RegulatoryU.S FDA
Zydus receives final approval from US FDA for Vigabatrin tablets
by adminby adminSummary : Vigabatrin is used to treat babies, one month to two years old with infantile spasms. Zydus has received final approval…
-
Global MarketRegulatoryU.S FDA
Swiss drugmaker Idorsia’s insomnia medicine gets US FDA’s approval
by adminby adminSummary : The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg…
-
Global MarketRegulatoryU.S FDA
US FDA clears Jubilant Therapeutics’ IND for novel dual LSD1 & HDAC6 inhibitor, JBI-802 for treatment of solid tumours
by adminby adminSynopsis: Jubilant Therapeutics Inc, a biopharmaceutical company, announced US Food and Drug Administration (FDA) clearance of the investigational new drug application (IND)…
-
AgrochemicalsGlobal Market
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
by adminby adminBlueprint Medicines Corporation a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on…
-
AgrochemicalsGlobal Market
Blueprint Medicines Completes Acquisition of Lengo Therapeutics
by adminby adminSummary : – Expands Blueprint Medicines’ lung cancer pipeline with LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion…
-
RegulatoryU.S FDA
Granules India Ltd gets USFDA nod for its Generic Amphetamine Mixed Salts
by adminby adminSummary : Granules India on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts…